
Agilent Technologies Inc (NYSE:A)

Intrinsic Value
The intrinsic value of one
A
stock under the Base Case scenario is
115.46
USD.
Compared to the current market price of 121.29 USD,
Agilent Technologies Inc
is
Overvalued by 5%.
The Intrinsic Value is calculated as the average of the two valuation methods:

Fundamental Analysis
A Profitability Score
Profitability Due Diligence
Agilent Technologies Inc's profitability score is 63/100. The higher the profitability score, the more profitable the company is.
Score
Agilent Technologies Inc's profitability score is 63/100. The higher the profitability score, the more profitable the company is.
A Solvency Score
Solvency Due Diligence
Agilent Technologies Inc's solvency score is 76/100. The higher the solvency score, the more solvent the company is.
Score
Agilent Technologies Inc's solvency score is 76/100. The higher the solvency score, the more solvent the company is.
Wall Street
Price Targets
A Price Targets
Price Targets made by Wall Street
12-month price targets for A stock made by Wall Street professionals. The average price target is 152.46 USD with a low forecast of 131.3 USD and a high forecast of 183.75 USD.
Insider Trading
A Insider Trading
Buy and sell transactions by insiders
During the last 3 months Agilent Technologies Inc insiders have not bought any shares, and sold 749k USD worth of shares. The last transaction was made on Jun 2, 2022 by Jacob Thaysen, who sold 749k USD worth of A shares.
Company Profile

Country
Industry
Market Cap
Dividend Yield
Description
Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. The company is headquartered in Santa Clara, California and currently employs 17,200 full-time employees. The firm operates in the life sciences, diagnostics and applied chemical markets. Its life sciences and applied markets business provides application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics business includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses. Its Agilent CrossLab business spans the entire lab with its range of services portfolio, which is designed to improve customer outcomes. Its product categories include liquid chromatography (LC) systems and components, atomic absorption (AA) instruments and others.
Contact
IPO
Employees
Officers
A Stock FAQ
The intrinsic value of one
A
stock under the Base Case scenario is
115.46
USD.
Compared to the current market price of 121.29 USD, Agilent Technologies Inc is Overvalued by 5%.